Concluded·Day 5·in the edition since 25 Sep 2026·8 sources·updated 29 Sep 2026

Claude agents' ART enzyme system discovery

The gist

Claude Agents Discover Novel Enzyme System in Bacteriophages

The result is the first output from Anthropic's in-house biology laboratory and demonstrates a multi-agent AI system completing a hypothesis-generation task that would typically take expert scientists weeks to months. Whether ART proves biologically significant depends on further experiments that have not yet been completed.

The full picture

Anthropic's life sciences research group, formed in spring 2026 with its own Bay Area laboratory, used a swarm of 949 Claude agents to autonomously search a massive DNA sequence database and identify a previously uncharacterized enzyme system in bacteriophages, named ART (array-associated reverse transcriptases). The campaign ran 21.5 hours without human input, spanning 949 agent sessions and processing 215.6 million tokens across 1.94 billion protein clusters. The agents gathered over 200,000 reverse transcriptase clusters, scored 3,564 candidate partner families, and produced 19 human-readable reports for scientists to review. One agent flagged a long array of evenly spaced DNA repeats beside an enzyme gene, a structural pattern reminiscent of CRISPR. The ART system consists of a reverse transcriptase, a partner gene, and the repeat array. Wet-lab tests confirmed the array is read out as distinct short RNAs, comprising up to 8% of a Staphylococcus phage's RNA 15 minutes after infection. Claude led the literature review and proposed experiments largely on its own; human researchers then executed them. The team published a pre-print and invited scientific collaboration. The biological function of ART remains unknown, and the findings have not been peer reviewed.

How it developed

29 September 2026

Feng Zhang, reviewing the pre-print Anthropic released September 23, said the identification of RNA-repeat arrays associated with reverse transcriptases is 'genuinely intriguing and merits further investigation'.

One commentator characterized the discovery as modest as an isolated biology result but significant as a point on an AI capability trendline. The pre-print describes 949 Claude agents running 21.5 hours to identify ART, a novel reverse-transcriptase system in bacteriophage DNA, without human input.

First citedThe Neuron

25 September 2026

Lucas Harrington, a CRISPR researcher, said on September 25 that figuring out what the system actually does is "where the real discoveries come from," and that announcing early, incremental findings with the framing of a major discovery "doesn't help", responding to Anthropic's pre-print identifying a novel reverse transcriptase system in bacteriophage DNA.

Additional detail confirmed Claude led the literature review and proposed experiments mostly on its own before human scientists executed them, and Amodei said he would have been proud of the result as a PhD student.

First citedTransformer News

First in the edition · 25 September 2026

24 September 2026

Dario Amodei said Claude led the discovery work on ART, an uncharacterized reverse transcriptase system his team reported in bacteriophage DNA on September 23, while humans chose the search domain and ran wet-lab validation.

He connected the result to his broader claim that AI could help cure most diseases within five to ten years. One observer characterized the finding as modest as an isolated biology result but meaningful as a signal of AI capability in new scientific domains.

First citedThe Neuron Zvi's AI Roundups

23 September 2026

Anthropic published a pre-print on September 23 describing ART, a previously uncharacterized reverse transcriptase system in bacteriophages, found by Claude AI agents running autonomously for 21.5 hours across 1.94 billion protein clusters.

Wet-lab tests confirmed the ART repeat array is transcribed as distinct short RNAs comprising up to 8% of a Staphylococcus phage's RNA 15 minutes after infection, though enzyme activity has not been demonstrated and the findings are not peer reviewed. Anthropic published early to demonstrate Claude's capabilities and invited scientists to propose research questions, with further experiments underway.

First citedAnthropic News Rohan Paul Twitter investing.com thenextweb.com+1

18 September 2026

Anthropic reported Claude's share of leading internal R&D tasks grew from 1% in March to 26% by August, with 30,000 agents active on its platform

17 September 2026

Anthropic launched the Life Sciences Verification Program, opening tiered verified access to less-restricted biology-focused models

Sources

The Neuron

Rohan Paul Twitter

Anthropic News